Quest Diagnostics teams up with Google Cloud to streamline data and personalize customer experiences using gen AI.

Under the partnership, the Secaucus-based company becomes the first national laboratory to implement these services across a range of areas.

Baird raised the firm’s price target on Quest Diagnostics (DGX) to $191 from $190 and keeps an Outperform rating on the shares. The firm ...

GE Healthcare, Synchron and robotics companies were among the medtech firms that used Nvidia’s GTC 2025 conference to share ...

Quest Diagnostics (NYSE:DGX) said on Wednesday that it expects first quarter revenue and EPS to take a hit from the weather ...

B, consensus $10.78B. Sees cash provided by operations $1.45B, and Capital expenditures $500M. For the Q1, the company now expects that worse-than-anticipated weather during the period will create a ...

This was the stock's second consecutive day of losses.

The board of Quest Diagnostics Incorporated ( NYSE:DGX ) has announced that it will be paying its dividend of $0.80 ...

This was the stock's third consecutive day of gains.

Quest Diagnostics announced it is teaming up with Google Cloud to develop artificial intelligence programs that can ...

Shares of Quest Diagnostics (NYSE: NYSE:DGX) tumbled 4.75% today after the company provided long-term guidance that failed to meet investor expectations. Despite reaffirming its full-year 2025 ...

Investing.com -- Quest Diagnostics (NYSE: NYSE: DGX ), a prominent player in diagnostic information services, announced today ...